Paul J. Martin

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A combined biomarker and clinical panel for chronic graft versus host disease diagnosis

M. Sarwal, J. Pidala, Stephanie J. Lee, 2016, The journal of pathology. Clinical research.

bone marrow transplantation Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic

K. Sullivan, D. Douek, R. Storb, 2011 .

THE USE OF RADIOLABELED ANTI‐CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA

I. Bernstein, J. Eary, W. Nelp, 1992, Transplantation.

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

H. Deeg, J. Radich, S. Heimfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.

H. Deeg, R. Storb, B. Sandmaier, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.

H. Deeg, P. Hari, M. Sorror, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft Versus Host Disease.

M. Boeckh, Stephanie J. Lee, K. Syrjala, 2021, Transplantation and cellular therapy.

Evidence for a multistep pathogenesis of chronic myelogenous leukemia.

V. Najfeld, P. Fialkow, J. Hansen, 1981 .

Hematopoietic stem cell transplants from unrelated donors

J. Hansen, E. Petersdorf, C. Anasetti, 1997, Immunological reviews.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

J. Ritz, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

H. Greinix, Stephanie J. Lee, M. Flowers, 2015 .

Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.

Tueng T. Shen, Tueng Shen, J. Pidala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

disease: a multicenter study Performance of a new clinical grading system for chronic graft-versus-host

J. Lynch, M. Horowitz, Stephanie J. Lee, 2013 .

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Blood.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

R. Storb, B. Storer, F. Appelbaum, 2011, Blood.

Therapy with mycophenolate mofetil for refractory acute and chronic graft-versus-host disease

H. Deeg, K. Sullivan, R. Storb, 2009, Bone Marrow Transplantation.

Biology and management of chronic graft-versus-host disease.

Paul J. Martin, S. Pavletic, P. Martin, 2009, Cancer treatment and research.

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.

Stephanie J. Lee, Paul J. Martin, L. M. Griffith, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Duration of immunosuppressive treatment for chronic graft-versus-host disease.

R. Storb, B. Storer, F. Appelbaum, 2004, Blood.

Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.

J. Lynch, S. Piantadosi, M. Horowitz, 2003, Blood.

Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, B. Storer, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD28 Signal Enhances Apoptosis of CD8 T Cells After Strong TCR Ligation 1

C. Anasetti, Paul J. Martin, Xue-Zhong Yu, 2003, The Journal of Immunology.

Genetic risk factors for sclerotic graft-versus-host disease.

L. Zhao, B. Storer, E. Warren, 2014, Blood.

Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation

D. Friedman, B. Mueller, Stephanie J. Lee, 2011, Annals of Internal Medicine.

Effects of race on survival after stem cell transplantation.

R. Storb, T. Gooley, M. Mielcarek, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1.

I. Bernstein, Paul J. Martin, B. Varnum-Finney, 2006, Blood.

W. Wood, B. Storer, J. Pidala, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

K. Washington, T. Morton, D. Kleiner, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

M. Washington, Z. Argényi, A. Rashid, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease

Hua Yu, Xiwei Wu, M. Muschen, 2017, Nature Communications.

Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.

M. Sorror, R. Storb, B. Sandmaier, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myeloablative Transplant (HCT)

Paul J. Martin, G. Ragnarsson, P. Martin, 2012 .

Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia.

J. Radich, M. Mauro, M. Flowers, 2017, Blood.

Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

S. Heckbert, T. Gooley, Paul J. Martin, 2003, American journal of respiratory and critical care medicine.

Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.

R. Storb, F. Appelbaum, J. Hansen, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia.

J. Radich, F. Appelbaum, M. Flowers, 2007, Blood.

Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.

H. Deeg, R. Storb, F. Appelbaum, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Homotypic aggregation of human cell lines by HLA class II‐, class Ia‐ and HLA‐G‐specific monoclonal antibodies

J. Ledbetter, D. Geraghty, J. Hansen, 1991, European journal of immunology.

A phase I / II trial of iodine-131 – tositumomab ( anti-CD 20 ) , etoposide , cyclophosphamide , and autologous stem cell transplantation for relapsed B-cell lymphomas

S. A. Bush, I. Bernstein, J. Eary, 2000 .

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.

B. Storer, G. Armstrong, S. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Research Methodology and Study Design

B. Storer, S. Bhatia, B. Shaw, 2016 .

An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation

M. Hegel, W. Leisenring, J. Romano, 2018, Journal of Cancer Survivorship.

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma.

R. Storb, B. Sandmaier, D. Maloney, 2017, Blood advances.

-inducible chemokines γ prominence of IFN- Chemokine expression in Th1 cell-induced lung injury:

D. Madtes, A. Dixon, Paul J. Martin, 2016 .

Chemokine expression in Th 1 cell-induced lung injury : prominence of IFN-g-inducible chemokines

D. Madtes, A. Dixon, Paul J. Martin, 2000 .

Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.

Mingfeng Zhang, S. Forman, James S. Young, 2016, Blood.

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

B. Storer, T. Panzarella, M. Aljurf, 2016, Blood.

Confounding Factors Affecting the National Institutes of Health (NIH) Chronic Graft-Versus-Host Disease Organ-Specific Score and Global Severity

B. Sandmaier, B. Storer, Stephanie J. Lee, 2016, Bone Marrow Transplantation.

Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80

Paul J. Martin, K. Cassady, D. Zeng, 2018, Front. Immunol..

Activation of Alveolar Macrophages Mononuclear Cell Inflammation and Cells Is Characterized by Host-Derived Lung Injury Induced by Alloreactive Th 1

D. Madtes, R. Hackman, M. Cheever, 1998 .

HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE 2014 NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. Pathology Working Group Report

M. Washington, Z. Argényi, A. Rashid, 2006 .

Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.

D. Madtes, Paul J. Martin, J. Edelman, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic graft-versus-host disease: how can we release Prometheus?

R. Soiffer, T. Wynn, Paul J. Martin, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.

Y. Ishii, Y. Efebera, L. Lekakis, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients.

Wei He, S. Forman, Can Liu, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Chronic Graft-vs.-Host Disease Failure-Free Survival (cGVHD-FFS) index.

B. Storer, J. Pidala, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2017, Blood.

FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation

J. Pidala, Stephanie J. Lee, M. Flowers, 2016 .

Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bandage Soft Contact Lenses for Ocular Graft-versus-Host Disease.

Ruikang K. Wang, Tueng T. Shen, B. Storer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pulmonary symptoms measured by the NIH Lung score predict overall survival, non-relapse mortality and patient-reported outcomes in chronic GVHD

W. Wood, B. Kurland, J. Pidala, 2014 .

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

W. Wood, B. Kurland, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.

B. Storer, K. van Besien, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison between short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease

B. Storer, Stephanie J. Lee, D. Couriel, 2011 .

Current challenges in chronic graft-versus-host disease.

J. Ritz, G. Socié, Paul J. Martin, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes

Ming-Tseh Lin, B. Storer, J. Hansen, 2008, Immunologic research.

Impact of molecular histocompatibility typing on outcome of unrelated donor hematopoietic cell transplantation

J. Hansen, E. Petersdorf, C. Anasetti, 2002 .

The biological significance of HLA‐DP gene variation in haematopoietic cell transplantation

Anajane G. Smith, J. Hansen, M. Malkki, 2001, British journal of haematology.

Disparity for a newly identified minor histocompatibility antigen, HA‐8, correlates with acute graft‐versus‐host disease after haematopoietic stem cell transplantation from an HLA‐identical sibling

Ming-Tseh Lin, V. Engelhard, E. Warren, 2003, British journal of haematology.

Pitfalls in the design of clinical trials for prevention or treatment of acute graft-versus-host disease.

Paul J. Martin, R. Nash, P. Martin, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Murine Models Provide New Insights Into Pathogenesis of Chronic Graft-Versus-Host Disease in Humans

Paul J. Martin, D. Zeng, Qingxiao Song, 2021, Frontiers in Immunology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Predominant Pulmonary Vasculitis CD 45 Induce Graft-Versus-Host Disease with T Cells Specific for a Polymorphic Segment of Kusunoki

D. Madtes, G. Chatta, R. Hackman, 1998 .

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.

J. Pidala, H. Greinix, V. Bhatt, 2021, Transplantation and cellular therapy.

Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host-disease-associated autoimmunity.

A. Riggs, Xiwei Wu, K. Haas, 2020, The Journal of clinical investigation.

Allogeneic hematopoietic stem cell transplantation for myelofibrosis.

H. Deeg, J. Radich, R. Storb, 2003, Blood.

Prospective phase II trial of montelukast to treat bronchiolitis obliterans syndrome after hematopoietic cell transplant and investigation into BOS pathogenesis.

S. Steinberg, Stephanie J. Lee, J. Gea-Banacloche, 2022, Transplantation and cellular therapy.

Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.

M. Sorror, R. Storb, W. Leisenring, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.

M. Sorror, R. Storb, W. Leisenring, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase

K. Sullivan, R. Storb, F. Appelbaum, 1998 .

Lung function and long-term complications after allogeneic hematopoietic cell transplant.

P. Campregher, Paul J. Martin, J. Chien, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006 .

Unusual distribution of Ia-like antigens on canine lymphocytes

R. Storb, Paul J. Martin, G. Sale, 2004, Immunogenetics.

Phenotyping human leukemic T-Cell lines: Enzyme markers; surface antigens, and cytogenetics

J. Hansen, Paul J. Martin, E. Giblett, 2004, Immunogenetics.

Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.

S. Schwartz, W. Leisenring, M. Boeckh, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A novel soluble form of Tim-3 associated with severe graft-versus-host disease.

S. Hanash, B. Storer, Chee-Hong Wong, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Endpoints for Clinical Trials Testing Treatment of Acute Graft- versus-host Disease: A Consensus Document

R. Soiffer, P. McCarthy, M. MacMillan, 2010 .

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.

E. Shpall, R. Soiffer, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of CD 28 in Acute Graft-Versus-Host Disease

C. Anasetti, Paul J. Martin, Xue-Zhong Yu, 1998 .

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

J. Fay, B. Storer, J. Wingard, 2009, Blood.

Chapter 2 – Monoclonal Antilymphocyte Antibodies: Probes for the Study of the Regulation of Hematopoiesis and Potential Clinical Applications1

J. Hansen, Paul J. Martin, B. Torok-Storb, 1983 .

Extending Postgrafting Cyclosporine Decreases the Risk of Severe Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell Transplantation

R. Storb, F. Baron, B. Sandmaier, 2006, Transplantation.

Graft-Versus-Host Disease in Mice CD28-Specific Antibody Prevents

Paul J. Martin, Xue-Zhong Yu, S. Bidwell, 2017 .

CD28-Specific Antibody Prevents Graft-Versus-Host Disease in Mice1

C. Anasetti, Paul J. Martin, Xue-Zhong Yu, 2000, The Journal of Immunology.

Clinical Marrow Transplantation

J. Hansen, P. Beatty, Paul J. Martin, 1987 .

Studies of T Cell Proliferation Induced by Monoclonal Antibodies of the Second International Workshop

E. Clark, J. Ledbetter, J. Hansen, 1986 .

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.

H. Deeg, K. Loeb, M. Sorror, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation and aging.

I. M. Jones, H. Deeg, L. Constine, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE: NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. The 2014 Pathology Working Group Report

T. Morton, D. Kleiner, J. Greenson, 2015 .

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

TRANSPLANTATION Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013 .

Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease.

B. Storer, E. Warren, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Progress in chronic graft-versus-host disease

Paul J. Martin, P. Martin, 2011, Revista brasileira de hematologia e hemoterapia.

Biology of chronic graft-versus-host disease: implications for a future therapeutic approach.

Paul J. Martin, P. Martin, 2008, The Keio journal of medicine.

Study design and endpoints in graft-versus-host disease.

Paul J. Martin, P. Martin, 2008, Best practice & research. Clinical haematology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.

S. Hirschfeld, Stephanie J. Lee, M. Flowers, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.

J. Radich, B. Storer, F. Appelbaum, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

J. Wingard, K. Ballen, Y. Nieto, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.

C. Anasetti, Paul J. Martin, M. Albert, 2004, The Journal of clinical investigation.

Myelodysplastic Syndrome : The Transplanter ’ s Quandaries

W. Murphy, S. Devine, C. Anasetti, 2008 .

Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation.

M. Horowitz, V. Paton, D. Weisdorf, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.

S. Heimfeld, R. Storb, B. Sandmaier, 2009, Blood.

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

H. Deeg, J. Hansen, Paul J. Martin, 1985 .

Monoclonal antibody 9.3 and anti‐CD11 antibodies define reciprocal subsets of lymphocytes

J. Hansen, P. Beatty, Paul J. Martin, 1985, European journal of immunology.

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

M. Sorror, R. Storb, B. Sandmaier, 2020, Annals of Internal Medicine.

Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long‐term follow‐up

R. Storb, W. Leisenring, Paul J. Martin, 2005, British journal of haematology.

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

I. Bernstein, J. Eary, F. Appelbaum, 2004 .

Evolution of epitopes on human and nonhuman primate lymphocyte cell surface antigens

E. Clark, J. Ledbetter, J. Hansen, 2004, Immunogenetics.

Prediction of outcomes after second-line treatment for acute graft-versus-host disease

M. Sorror, M. MacMillan, T. Gooley, 2022, Blood advances.

How I treat steroid-refractory acute graft-versus-host disease.

Paul J. Martin, P. Martin, 2020, Blood.

Secondary treatment of acute graft-versus-host disease: a critical review.

M. Flowers, Paul J. Martin, P. Carpenter, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ANG2/VEGF in steroid-refractory GVHD.

Paul J. Martin, P. Martin, 2011, Blood.

Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.

R. Storb, W. Leisenring, F. Appelbaum, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

SIROLIMUS (RAPAMYCIN) FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE1

H. Deeg, K. Sullivan, R. Storb, 2001, Transplantation.

Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.

B. Storer, J. Hansen, G. McDonald, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of acute GVHD treatment outcomes 1 PREDICTIVE VALUE OF CLINICAL FINDINGS AND PLASMA BIOMARKERS AFTER 14 DAYS OF PREDNISONE TREATMENT FOR ACUTE GRAFT-VERSUS-HOST DISEASE

B. Storer, J. Hansen, G. McDonald, 2017 .

Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.

B. Storer, J. Hansen, G. McDonald, 2015, Blood.

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.

R. Storb, B. Storer, F. Appelbaum, 2009, Blood.

Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, D. Maloney, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial

M. Maris, R. Storb, B. Sandmaier, 2016 .

Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation.

R. Storb, B. Storer, F. Appelbaum, 2011, Blood.

A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.

R. Storb, B. Storer, F. Appelbaum, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation

R. Storb, B. Storer, F. Appelbaum, 2014, Bone Marrow Transplantation.

Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease

R. Storb, B. Storer, M. Mielcarek, 2014, Haematologica.

Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, D. Maloney, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.

B. Storer, F. Appelbaum, E. Warren, 2009, Blood.

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2014, Blood.

Infections Post Transplant Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation

K. Sullivan, R. Storb, M. Boeckh, 2003 .

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients.

M. Bar, M. Sorror, B. Sandmaier, 2019, Blood advances.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2018, Haematologica.

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.

M. Bar, B. Storer, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

How I Treat How we treat chronic graft-versus-host disease

M. Flowers, Paul J. Martin, P. Martin, 2015 .

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.

H. Deeg, R. Storb, W. Leisenring, 2002, Blood.

Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism

Paul J. Martin, P. Martin, 1996 .

Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.

A. Riggs, Xiwei Wu, Paul J. Martin, 2021, Blood.

Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.

T. Hohl, B. Storer, E. Warren, 2017, Blood.

Delivering care to long-term adult survivors of hematopoietic cell transplantation.

Stephanie J. Lee, K. Syrjala, Paul J. Martin, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

rapamycin Prevention of lethal acute GVHD with an agonistic CD 28 antibody and

C. Anasetti, Paul J. Martin, M. Albert, 2004 .

The Future of Chronic Graft-Versus-Host Disease: Introduction to the 2020 National Institutes of Health Consensus Development Project Reports.

Stephanie J. Lee, Paul J. Martin, S. Pavletic, 2021, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report Transplantation and Cellular Therapy

J. Pidala, H. Greinix, V. Bhatt, 2021 .

A Phase 3 randomized study of Remestemcel-L versus placebo added to second line therapy in patients with steroid refractory acute graft versus host disease.

E. Shpall, R. Soiffer, E. Waller, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A PHASE I‐II STUDY EVALUATING THE MURINE ANTI‐IL-2 RECEPTOR ANTIBODY 2A3 FOR TREATMENT OF ACUTE GRAFT‐VERSUS-HOST DISEASE

K. Sullivan, R. Storb, F. Appelbaum, 1990, Transplantation.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic GVHD

B. Storer, J. Pidala, Stephanie J. Lee, 2019 .

Involvement of Donor T-Cell Cytotoxic Effector Mechanisms in Preventing Allogeneic Marrow Graft Rejection

M. Hahne, Paul J. Martin, G. Sale, 1998 .

Allogeneic Marrow Graft Rejection Involvement of Donor T-Cell Cytotoxic Effector Mechanisms in Preventing

M. Hahne, Paul J. Martin, Y. Akatsuka, 1998 .

Anti-CD3ε F(ab′)2 Prevents Graft-Versus-Host Disease by Selectively Depleting Donor T Cells Activated by Recipient Alloantigens1

C. Anasetti, Paul J. Martin, Xue-Zhong Yu, 2001, The Journal of Immunology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report Transplantation and Cellular Therapy

Shannon R. McCurdy, R. Jenq, R. Lafyatis, 2021 .

Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.

M. Norkin, S. Mineishi, M. Krem, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-Versus-Host Reaction T Cells in the + Antigen-Specific CD 8 Visualization , Fate , and Pathogenicity of Anasetti

C. Anasetti, Paul J. Martin, Xue-Zhong Yu, 1999 .

IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells

Paul J. Martin, L. Lum, E. Burns, 1990, Journal of Clinical Immunology.

HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.

W. Leisenring, M. Boeckh, L. Corey, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A new human T-cell differentiation antigen: Unexpected expression on chronic lymphocytic leukemia cells

J. Hansen, Paul J. Martin, R. Nowinski, 2005, Immunogenetics.

Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK Pathway

H. Stark, S. Mehrotra, B. Ogretmen, 2022, Leukemia.

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.

S. A. Bush, I. Bernstein, J. Eary, 2003, Blood.

Evaluation of Thalidomide for Treatment or Prevention of Chronic Graft-versus-host Disease

M. Flowers, Paul J. Martin, P. Martin, 2003, Leukemia & lymphoma.

Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin

H. Deeg, C. McFarland, M. Sorror, 2021, Bone Marrow Transplantation.

Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease

J. Pidala, Stephanie J. Lee, M. Flowers, 2015, Haematologica.

chronic GVHD Evaluation of NIH consensus criteria for classification of late acute and

B. Storer, F. Appelbaum, E. Warren, 2009 .

prednisone does not compromise patient outcomes Initial therapy of acute graft-versus-host disease with low-dose

R. Storb, B. Storer, F. Appelbaum, 2009 .

Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.

B. Storer, F. Appelbaum, E. Warren, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation for myeloﬁbrosis

H. Deeg, J. Radich, R. Storb, 2003 .

Airflow Decline after Myeloablative Allogeneic Hematopoietic Cell Transplantation: The Role of Community Respiratory Viruses

M. Boeckh, L. Corey, Paul J. Martin, 2006, The Journal of infectious diseases.

PD-L 1 interacts with CD 80 to regulate graft-versus-leukemia activity of donor CD 8 + T cells

Mingfeng Zhang, Haidong Dong, S. Forman, 2018 .

PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells

Mingfeng Zhang, Haidong Dong, S. Forman, 2017, The Journal of clinical investigation.

Persistence of Graft-Versus-Host Disease T Cells and + Infiltrating Donor CD 8 Parenchymal Cells Leads to Expansion of Loss of B 7-H 1 Expression by Recipient

Lieping Chen, Z. Meng, Wei He, 2011 .

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation

B. Storer, J. Hansen, S. Spellman, 2022, Blood advances.

Comorbidity Burden in Patients with Chronic Graft Versus Host Disease

W. Wood, B. Storer, J. Pidala, 2014 .

Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.

H. Deeg, R. Storb, F. Appelbaum, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mantle Zone and Germinal Center B cells Respond to Different Activation Signals

E. Clark, J. Ledbetter, Paul J. Martin, 1985 .

Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease

K. Loeb, S. Heimfeld, B. Wood, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Risk Score for Mortality after Allogeneic Hematopoietic Cell Transplantation

D. Au, Paul J. Martin, J. Chien, 2006, Annals of Internal Medicine.

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells.

H. Deeg, J. Radich, B. Storer, 2003, Blood.

Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial

H. Deeg, M. Pepe, K. Sullivan, 1989, British journal of haematology.

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.

R. Storb, B. Storer, F. Appelbaum, 2016, Blood.

allogeneic hematopoietic stem cells Conditioning with fludarabine and targeted busulfan for transplantation of

J. Radich, B. Storer, F. Appelbaum, 2013 .

Allogeneic and Syngeneic Marrow Transplantation for Aplastic Anemia: Overview of Seattle

J. Singer, K. Sullivan, R. Storb, 1988 .

Engraftment, Graft Rejection, and Graft Failure

Paul J. Martin, R. Levy, P. Martin, 2019, Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation.

Response to Krejci and Mayer

G. McDonald, Paul J. Martin, P. Martin, 2010 .

Antithymocyte Globulin Aplastic Anemia Conditioned by Cyclophosphamide Combined With Long-Term Follow-Up of Allogeneic Marrow Transplants in Patients With

K. Sullivan, R. Storb, F. Appelbaum, 2011 .

CD34 Cell Dose and Chronic Graft-versus-Host Disease after Human Leukocyte Antigen-Matched Sibling Hematopoietic Stem Cell Transplantation

S. Heimfeld, R. Storb, M. Mielcarek, 2004, Leukemia & lymphoma.

Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias.

K. Sullivan, R. Storb, H. Kiem, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Use of Flow Microfluorometry in Bone Marrow Transplantation a

J. Hansen, Paul J. Martin, E. Thomas, 1984, Annals of the New York Academy of Sciences.

A survey of diagnosis, management, and grading of chronic GVHD.

M. Horowitz, Stephanie J. Lee, M. Flowers, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ncreasingly Frequent Diagnosis of Acute astrointestinal Graft-versus-Host Disease after llogeneic Hematopoietic Cell Transplantation

R. Storb, F. Appelbaum, J. Hansen, 2004 .

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.

R. Soiffer, Paul J. Martin, J. Ferrara, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period.

Z. Argényi, B. Storer, K. Guthrie, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pathogenic neutrophils in acute GVHD.

Paul J. Martin, P. Martin, 2018, Blood.

Long-Term Comparison of Immunosuppressive Therapy with Antithymocyte Globulin to Bone Marrow Transplantation in Aplastic Anemia

J. Singer, K. Sullivan, R. Storb, 1990 .

Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness.

R. Jenq, M. Mohty, E. Holler, 2020, Blood.

131I-Anti-CD45 Antibody Plus Fludarabine, Low-Dose Total Body Irradiation and Peripheral Blood Stem Cell Infusion for Elderly Patients with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).

H. Deeg, M. Maris, R. Storb, 2005 .

S. Hanash, J. Pidala, Stephanie J. Lee, 2020, Blood advances.

Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.

B. Storer, A. Kariminia, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New Strategies for Fungal Infections after Hematopoietic Cell Transplantation : Prevention or Preemption ?

Treasurer, H. Heslop, R. Soiffer, 2007 .

Diagnosis and clinical management of chronic graft-versus-host disease

M. Flowers, Paul J. Martin, J. Sanders, 2004, International journal of hematology.

Allogeneic marrow transplantation

J. Hansen, E. Petersdorf, C. Anasetti, 1993 .

Visual Acuity and Anterior Segment Findings in Chronic Graft-Versus-Host Disease

M. Flowers, Paul J. Martin, Michelle P. Lin, 2011, Cornea.

Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host disease.

B. Storer, S. Pergam, Paul J. Martin, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)

M. Sorror, R. Storb, B. Storer, 2013 .

Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose.

M. Bar, P. Hari, R. Storb, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Signal transduction by HLA class II antigens expressed on activated T cells

G. Schieven, J. Ledbetter, J. Hansen, 1991, European journal of immunology.

Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation

S. Sutton, H. Jim, P. Jacobsen, 2016, Cancer.

Resilience, health, and quality of life among long‐term survivors of hematopoietic cell transplantation

Stephanie J. Lee, A. Rosenberg, K. Syrjala, 2015, Cancer.

Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors.

W. Leisenring, Stephanie J. Lee, K. Syrjala, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Daniel Wolff, Yoshihiro Inamoto, Sandra A Mitchell, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Michael Boeckh, Kieren A Marr, M. Sorror, 2010, The New England journal of medicine.

Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease.

M. Flowers, W. Hwang, S. Forman, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation

W. Wood, D. Miklos, B. Storer, 2015, Clinical Cancer Research.

Involvement of the B-lymphoid system in chronic myelogenous leukaemia

V. Najfeld, J. Hansen, Paul J. Martin, 1980, Nature.

Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial

H. Deeg, K. Sullivan, R. Storb, 1997 .

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.

M. Maris, R. Storb, B. Sandmaier, 2003, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Shannon R. McCurdy, R. Jenq, G. Cuvelier, 2021, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.

B. Storer, F. Appelbaum, J. Hansen, 2002, Blood.

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

M. Maris, R. Storb, B. Sandmaier, 2003, Blood.

Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation.

H. Deeg, M. Maris, R. Storb, 2003, Blood.

Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.

M. Tallman, R. Gale, M. Flowers, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Success of allogeneic marrow transplantation for children with severe aplastic anaemia

H. Deeg, R. Storb, B. Storer, 2012, British journal of haematology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Anita Lawitschka, Stephanie J. Lee, K. Syrjala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: improved outcomes over two decades

P. Hari, M. Sorror, M. Maris, 2020, Haematologica.

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

R. Storb, B. Storer, M. Boeckh, 2015, Haematologica.

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

E. Estey, M. Sorror, M. Maris, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.